FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HARRIS ROBERT LEWIS 		2. Issuer Name and Ticker or Trading Symbol

AMARANTUS BIOSCIENCE, INC. [ AMBS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

402 SEQUOYAH ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/13/2010
(Street)

OAKLAND, CA 94605-4538
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   7/26/2012   7/26/2012   P    7000   A $0.015   1344332   D    
Common Stock   1/14/2013   1/14/2013   P   V 50000   A $0.098   1394.332   D    
Convertible Series B Preferred Stock   7/15/2012   7/15/2012   A    31250   A $0.001   31250   D    
Convertible Series B Preferred Stock   11/4/2012   11/4/2012   A    100000   A $0.001   131250   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Convertible Note   $0.04   12/13/2010     (3) A      1         (1)   (1) Common Stock   2761986   $50000   2761986   D    
Convertible Note   $0.04   4/27/2010     (3) A      1         (1)   (1) Common Stock   1357877   $100000   4119863   D    
Convertible Note   $0.04   8/27/2011     (3) A      1         (1)   (1) Common Stock   1279178   $50000   5399041   D    
5% Convertible Preferred Stock   $1.50   7/15/2012     (3) A      31250         (1)   (1) Common Stock   1562500     (2) 6961541   D    
5% Convertible Preferred Stock   $1.50   11/4/2012     (3) A      100000         (1)   (1) Common Stock   5000000     (2) 11961541   D    

Explanation of Responses:
( 1)  No specific date set.
( 2)  Set based upon current price, actual price will be determine on the date of conversion.
( 3)  N/A

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HARRIS ROBERT LEWIS
402 SEQUOYAH ROAD
OAKLAND, CA 94605-4538 		X



Signatures
/s/ Robert L. Harris 1/16/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Amarantus Bioscience (CE) Charts.
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Amarantus Bioscience (CE) Charts.